207 related articles for article (PubMed ID: 20934874)
1. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
[TBL] [Abstract][Full Text] [Related]
7. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
9. Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation.
Mishra N; Sasmal D
Bioorg Med Chem Lett; 2011 Apr; 21(7):1969-73. PubMed ID: 21377879
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
[TBL] [Abstract][Full Text] [Related]
11. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
12. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.
Maccioni E; Alcaro S; Orallo F; Cardia MC; Distinto S; Costa G; Yanez M; Sanna ML; Vigo S; Meleddu R; Secci D
Eur J Med Chem; 2010 Oct; 45(10):4490-8. PubMed ID: 20702005
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
Palaska E; Aydin F; Uçar G; Erol D
Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
[TBL] [Abstract][Full Text] [Related]
15. 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.
Ucar G; Gokhan N; Yesilada A; Bilgin AA
Neurosci Lett; 2005 Jul; 382(3):327-31. PubMed ID: 15925113
[TBL] [Abstract][Full Text] [Related]
16. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA
Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
[TBL] [Abstract][Full Text] [Related]
18. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
